MedPath

Efficacy and feasibility of software for the treatment of obsessive compulsive disorder: a pilot study

Not Applicable
Conditions
Obsessive compulsive disorder
Registration Number
JPRN-UMIN000048120
Lead Sponsor
Kyoto University
Brief Summary

Three patients participated in the study. The OCD symptoms and depression improved in all the patients(Y-BOCS 21 to 16, 21 to 6, 18 to 13; OCI 46 to 18, 23 to 14, 40 to 27; PHQ-9 4 to 1, 12 to 3, 16 to 10). The symptoms of anxiety did not change or worsen (OASIS 4 to 4, 2 to 3, 7 to 7). The sessions completed were 10 (25%), 19 (47.5%), 13 (32.5%).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
3
Inclusion Criteria

Not provided

Exclusion Criteria

High risk of suicide, self-harm, admission. Those who cannnot answer the questionnaire du to the lack of ability. Those who don't have computer or smartphone. Those who have received CBT or those who will receive CBT during this trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath